Percentage of Participants With Any Confirmed Relapse of Immune-mediated Disease (RA, IBD, or RRMS);Percentage of Participants With Medically Attended AEs (MAAEs), Serious Adverse Events (SAEs) and Adverse Events of Special Interest (AESI);Percentage of Participants With Unsolicited Adverse Events (AEs)

Percentage of Participants With Any Confirmed Relapse of Immune-mediated Disease (RA, IBD, or RRMS);Percentage of Participants With Medically Attended AEs (MAAEs), Serious Adverse Events (SAEs) and Adverse Events of Special Interest (AESI);Percentage of Participants With Unsolicited Adverse Events (AEs)